Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
J Erik Fyrwald
J Erik Fyrwald is Chief Executive Officer at Eli Lilly. OQRO lists 22 transactions filed with the SEC under this name, the latest on Sep 22, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
22
Companies involved
2
Their past purchases, 90 days after disclosure
1 buy, median -2.6% vs S&P 500, beat it 0 of 1 time.
Average -2.6% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Mar 16, 2026 to Mar 16, 2026, measured from the first close after the filing. Past results, not a forecast.